Taiko Pharmaceutical Co., Ltd. engages in the manufacture and sale of general medications particularly non-prescription gastrointestinal drugs and designated quasi drugs. It operates through the following segments: Pharmaceuticals, Infection Control, and Others. The Pharmaceuticals segment handles the sale of gastrointestinal drugs such as Seirogan, Seirogan Toui A, and Seirogan Quick C. The Infection Control segment offers hygiene products such as Cleverin and clev&and.
The Others segment provides vinegar-related products. The company was founded by Otojiro Shibata in July 1940 and is headquartered in Osaka, Japan.
Taiko Pharmaceutical Co., Ltd. has established itself as a well-known pharmaceutical company in Japan. The company has transitioned from a startup phase to a mature enterprise with a strong market presence and a diverse product portfolio. With steady revenue growth and continuous innovation, Taiko Pharmaceutical Co., Ltd. is now a key player in the healthcare industry, poised for further expansion and development.
Over the years, Taiko Pharmaceutical Co., Ltd. has achieved several significant milestones that have contributed to its success. The company has witnessed consistent revenue growth, expanded its market reach both domestically and internationally, and increased its customer base exponentially. Taiko Pharmaceutical Co., Ltd. has also focused on research and development, introducing innovative products that have garnered positive attention from consumers and industry experts.
Taiko Pharmaceutical Co., Ltd. has been involved in numerous impactful case studies and significant projects within the pharmaceutical and healthcare sectors. The company's products have been integral in improving patient outcomes and healthcare practices. With a focus on quality, efficacy, and safety, Taiko Pharmaceutical Co., Ltd.'s contributions to the industry have been widely recognized and appreciated.
-
Active
Health Care
Life Sciences
ORIX Honmachi Building, 16F 1-4-1 Nishi-Honmachi Nishi-Ku Osaka Osaka 550 Japan...
Japan
208
Takashi Shibata (President & Representative Director)
Makoto Horikawa (Director)
Takashi Shibata (President & Representative Director)
Tsuyoshi Honma (Executive Officer, Head-Accounting & IT)
ラッパ整腸薬BF
正露丸
セイロガン糖衣A
正露丸クイックC
ピシャット下痢止めOD錠
森の木酢物語シリーズ 木酢入浴液
クレベリン 置き型
クレベリン スプレー
クレベリン ミニスプレー
クレベリンpro 置き型 10m²用・20m²用
クレベリンpro 置き型 50m²用
クレベリンpro スプレー
クレベリンpro 希釈用液
クレベリンG スティックタイプ 6本用ケース
クレベリンG スティックタイプ 2本用ケース
クレベリンpro スティック くん蒸タイプ
クレベリン発生機 エレクローラー
クレベリン発生機 リスパスNEO
クレベリン発生機 リスパスS-Ⅱ
クレベリン発生機 AQC2000-Ⅱ
6.12 B
¥363
Achieving business success in today’s competitive landscape requires specialized expertise, seamless operations, and continuous innovation. Establishing a Virtual Delivery Center (VDC) can transform your company’s growth journey by ensuring efficiency, scalability, and long-term value.
Why Choose a VDC for Your Company?
1. Cost Optimization:
Save up to 70% on operational costs by leveraging remote teams and streamlined processes.
2. Expert Access:
Gain instant access to highly skilled professionals, ensuring faster and smoother project execution.
3. Scalable Teams:
Scale your team as business needs evolve, from initial project setup to long-term support.
4. Accelerated Timelines:
Leverage 24/7 global teams to reduce project delays and speed up implementation.
5. Continuous Support:
Ensure uninterrupted business performance with ongoing maintenance and updates.
Unlock Business Success with a VDC By establishing a VDC, your company can overcome operational challenges, achieve seamless system integration, and maximize ROI. Stay ahead in today’s dynamic market with a future-ready business strategy powered by a Virtual Delivery Center. Learn More About Us
Book A Meeting To Setup Your VDCAiDOOS Information Wiki provides comprehensive information about products, companies, and individuals.
-
Health Care
Life Sciences
ORIX Honmachi Building, 16F 1-4-1 Nishi-Honmachi Nishi-Ku Osaka Osaka 550 Japan...
Japan
208+
6.12 B
Taiko Pharmaceutical Co., Ltd. engages in the manufacture and sale of general medications particularly non-prescription gastrointestinal drugs and designated quasi drugs. It operates through the following segments: Pharmaceuticals, Infection Control, and Others. The Pharmaceuticals segment handles the sale of gastrointestinal drugs such as Seirogan, Seirogan Toui A, and Seirogan Quick C. The Infection Control segment offers hygiene products such as Cleverin and clev&and.
The Others segment provides vinegar-related products. The company was founded by Otojiro Shibata in July 1940 and is headquartered in Osaka, Japan.
Achieving business success in today’s competitive landscape requires specialized expertise, seamless operations, and continuous innovation. Establishing a Virtual Delivery Center (VDC) can transform your company’s growth journey by ensuring efficiency, scalability, and long-term value.
Why Choose a VDC for Your Company?
1. Cost Optimization:
Save up to 70% on operational costs by leveraging remote teams and streamlined processes.
2. Expert Access:
Gain instant access to highly skilled professionals, ensuring faster and smoother project execution.
3. Scalable Teams:
Scale your team as business needs evolve, from initial project setup to long-term support.
4. Accelerated Timelines:
Leverage 24/7 global teams to reduce project delays and speed up implementation.
5. Continuous Support:
Ensure uninterrupted business performance with ongoing maintenance and updates.
Unlock Business Success with a VDC By establishing a VDC, your company can overcome operational challenges, achieve seamless system integration, and maximize ROI. Stay ahead in today’s dynamic market with a future-ready business strategy powered by a Virtual Delivery Center. Learn More About Us
Book A Meeting To Setup Your VDC